Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019942

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 019942 describes INTRALIPID 30%, which is a drug marketed by Fresenius and is included in one NDA. It is available from one supplier. Additional details are available on the INTRALIPID 30% profile page.

The generic ingredient in INTRALIPID 30% is soybean oil. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for 019942
Tradename:INTRALIPID 30%
Ingredient:soybean oil
Formulation / Manufacturing:see details
Pharmacology for NDA: 019942
Suppliers and Packaging for NDA: 019942
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INTRALIPID 30% soybean oil INJECTABLE;INJECTION 019942 NDA Baxter Healthcare Corporation 0338-0520 0338-0520-13 500 mL in 1 BAG (0338-0520-13)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength30%
Approval Date:Dec 30, 1993TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.